XML 32 R7.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Deficit
Balance at beginning of period (in shares) at Dec. 31, 2017   296,209          
Balance at beginning of period at Dec. 31, 2017 $ 284,961 $ 296 $ 2,114,184 $ (347) $ (1,829,172)    
Balance at beginning of period (ASU 2014-09) at Dec. 31, 2017           $ 258,505 $ 258,505
Balance at beginning of period (ASU 2016-02) at Dec. 31, 2017           $ 234 $ 234
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 690,070       690,070    
Other comprehensive income (loss) (354)     (354)      
Issuance of common stock under equity incentive and stock purchase plans (in shares)   3,667          
Issuance of common stock under equity incentive and stock purchase plans 20,985 $ 4 20,981        
Stock transactions associated with taxes withheld on equity awards (7,574)   (7,574)        
Stock-based compensation 40,626   40,626        
Balance at end of period (in shares) at Dec. 28, 2018   299,876          
Balance at end of period at Dec. 28, 2018 1,287,453 $ 300 2,168,217 (701) (880,363)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 321,012       321,012    
Other comprehensive income (loss) 3,770     3,770      
Issuance of common stock under equity incentive and stock purchase plans (in shares)   4,955          
Issuance of common stock under equity incentive and stock purchase plans 27,037 $ 5 27,032        
Stock transactions associated with taxes withheld on equity awards (9,904)   (9,904)        
Stock-based compensation $ 56,602   56,602        
Balance at end of period (in shares) at Jan. 03, 2020 304,831 304,831          
Balance at end of period at Jan. 03, 2020 $ 1,685,970 $ 305 2,241,947 3,069 (559,351)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 111,781            
Other comprehensive income (loss) 1,407     1,407      
Issuance of common stock under equity incentive and stock purchase plans (in shares)   6,796          
Issuance of common stock under equity incentive and stock purchase plans 24,903 $ 7 24,896        
Stock transactions associated with taxes withheld on equity awards (50,018)   (50,018)        
Stock-based compensation $ 105,070   105,070        
Balance at end of period (in shares) at Jan. 01, 2021 311,627 311,627          
Balance at end of period at Jan. 01, 2021 $ 1,879,113 $ 312 $ 2,321,895 $ 4,476 $ (447,570)